PALBOCICLIB REAL WORLD DATA IN ADVANCED AND METASTATIC BREAST CANCER TREATED: A MULTICENTER EXPERIENCE IN LEBANON

被引：0
|
作者：
Nasr, Fadi [1 ,2 ,3 ]
Diab, Saada [1 ]
Al Ghoche, Ahmad [1 ]
Yehia, Intissar [1 ]
Nasr, Lewis [2 ]
机构：
[1] Balamand Univ Beirut, Dept Hematol Oncol, Mt Lebanon Univ Hosp, Beirut, Lebanon
[2] St Joseph Univ, Dept Hematol Oncol, Hotel Dieu France Univ Hosp, Fac Med, Beirut, Lebanon
[3] Univ St Esprit Kaslik, Notre Dame Secours Univ Hosp, Fac Med, Jounieh, Lebanon
来源：
BREAST | 2021年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO61
引用
收藏
页码：S48 / S48
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD SURVIVAL DATA OF PALBOCICLIB IN ADVANCED AND METASTATIC BREAST CANCER: A MULTICENTER EXPERIENCE IN LEBANON
    Nasr, Fadi
    Ghoche, Ahmad
    Diab, Saada
    Nasr, Lewis
    BREAST, 2019, 48 : S53 - S53
  • [2] Real-world survival data of palbociclib in advanced and metastatic breast cancer: A multicenter experience in Lebanon.
    Nasr, Lewis
    Ghoche, Ahmad
    Diab, Saada
    Nasr, Fadi
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [3] Palbociclib in hormone positive metastatic breast cancer: A real world multicenter Indian experience.
    Rauthan, Amit
    Patil, Poonam
    Somashekhar, S. P.
    Jacob, Linu Abraham
    Lokanatha, D.
    Kumar, Kishore
    Keechilat, Pavithran
    Vijayakumar, D. K.
    Patil, Shekar
    Shashidhara, H. P.
    Zaveri, Shabber
    Yashas, Nitin
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [4] REAL-WORLD OUTCOMES OF PATIENTS WITH ADVANCED BREAST CANCER TREATED WITH PALBOCICLIB: A MULTICENTER RETROSPECTIVE COHORT STUDY IN JAPAN
    Odan, Nina
    Kikawa, Yuichiro
    Matsumoto, Hajime
    Minohata, Junya
    Suwa, Hirohumi
    Hashimoto, Takashi
    Okuno, Toshitaka
    Miyashita, Masaru
    Saito, Masaru
    Yamagami, Kazuhiko
    Takao, Shintaro
    BREAST, 2019, 48 : S49 - S49
  • [5] Real-world experience of palbociclib and ribociclib: novel oral therapy in metastatic breast cancer
    M. García-Trevijano Cabetas
    P. Lucena Martínez
    I. Jiménez Nácher
    M. Díaz Almirón
    P. Zamora Auñón
    A. Herrero Ambrosio
    International Journal of Clinical Pharmacy, 2021, 43 : 893 - 899
  • [6] Real world experience of palbociclib in hormone receptor-positive metastatic breast cancer.
    Malik, Faizan
    Ali, Naveed
    Jafri, Syed Imran Mustafa
    Sundermeyer, Mark L.
    Seidman, Michael Jeffrey
    Fidler, Christian Joseph
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [7] Real-world experience of palbociclib and ribociclib: novel oral therapy in metastatic breast cancer
    Garcia-Trevijano Cabetas, M.
    Lucena Martinez, P.
    Jimenez Nacher, I.
    Diaz Almiron, M.
    Zamora Aunon, P.
    Herrero Ambrosio, A.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2021, 43 (04) : 893 - 899
  • [8] Real-World Data of Palbociclib in Combination With Endocrine Therapy for the Treatment of Metastatic Breast Cancer in Men
    Kraus, Albert L.
    Yu-Kite, Michelle
    Mardekian, Jack
    Cotter, Matthew J.
    Kim, Sindy
    Decembrino, Jaclyn
    Snow, Tamara
    Carson, Kenneth R.
    Rockland, Jillian Motyl
    Gossai, Anala
    Wilner, Keith
    Wang, Diane D.
    Bartlett, Cynthia Huang
    Oharu, Norihiko
    Schnell, Patrick
    VanArsdale, Todd
    Lu, Dongrui R.
    Tursi, Jennifer M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 111 (01) : 302 - 309
  • [9] Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
    Varella, Leticia
    Eziokwu, Akaolisa Samuel
    Jia, Xuefei
    Kruse, Megan
    Moore, Halle C. F.
    Budd, George Thomas
    Abraham, Jame
    Montero, Alberto J.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (02) : 429 - 434
  • [10] Real-world clinical outcomes and toxicity in metastatic breast cancer patients treated with palbociclib and endocrine therapy
    Leticia Varella
    Akaolisa Samuel Eziokwu
    Xuefei Jia
    Megan Kruse
    Halle C. F. Moore
    George Thomas Budd
    Jame Abraham
    Alberto J. Montero
    Breast Cancer Research and Treatment, 2019, 176 : 429 - 434
12345